A Study of Debio 025 (Alisporivir) Combined With Peg-IFNα2a and Ribavirin in Treatment naïve Chronic Hepatitis C Genotype 1 Patients

NCT00854802 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

290

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Debio 025
DRUG: Peg-IFNα2a
DRUG: Ribavirin
DRUG: Debio 025 placebo

Sponsor

Debiopharm International SA

Collaborators

[object Object]